Our results reveal that pharmacologic or genetic PRMT5 inhibition blocks the expression of SNAIL, TWIST, and ZEB1 and almost completely blocks metastases in aggressive in vivo tumor models. This evidence concerns the gene SNAI1 and neoplasm.